InvestorsHub Logo
Followers 2
Posts 62
Boards Moderated 0
Alias Born 07/02/2013

Re: None

Thursday, 06/04/2020 3:36:19 PM

Thursday, June 04, 2020 3:36:19 PM

Post# of 16700
I doubt it will take until 2022 to see significant price movement, we'll get data out of 2b fairly soon after they start. 2 week trial mixed in with making sure they aggregate data from correct scans, etc.

SK was always treated as a side project, so they aren't focusing much energy on it. They even said so. AGN is focusing entirely on the multinational trial.

CEO explained in last webcast why they do halts, "to let people digest news and make it fair".

Dramatic for a US company? definitely. Companies are pumping out stuff mid day all the time unless it's insanely big news.

Dramatic for a Canadian company? No idea, unless anyone trades there normally and knows the typical behavior.

I did not expect a big share movement today. All in all, getting FDA approval just means it is countdown until data. Whereas the beginning of the countdown was somewhat a little more murky beforehand.

You can either flip pennies, or you can just wait on the data, who cares what happens in between. The final SP will reflect the data, whether 0.05 or $5.00, anything in between is a waste of time unless you're flipping.